A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen

Haemophilia

Volumn 20, Issue 1, 2014, Pages 147-153

  Stufano, F ^a   Lawrie, A S ^b   La Marca, S ^a   Berbenni, C ^a   Baronciani, L ^a   Peyvandi, F ^a,c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Von Willebrand disease; Von Willebrand factor; VWF:Ag; VWF:RCo

Indexed keywords

ANTIGEN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR:ANTIGEN; VON WILLEBRAND FACTOR:RISTOCETIN COFACTOR;

ANALYTIC METHOD; ARTICLE; ASSAY; AUTOANALYZER; AUTOMATION; CHEMILUMINESCENCE ANALYZER; CHEMILUMINESCENT ANALYSER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMMUNOTURBIDIMETRIC ANALYSER; IMMUNOTURBIDIMETRY; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MEASUREMENT ACCURACY; MULTICENTER STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TURBIDIMETRY; VON WILLEBRAND DISEASE;

VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR; VWF:AG; VWF:RCO;

BLOOD COAGULATION TESTS; HUMANS; REPRODUCIBILITY OF RESULTS; RISTOCETIN; SENSITIVITY AND SPECIFICITY; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84890860246     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12264     Document Type: Article

References (21)

1. Sadler JE, Mannucci PM, Berntorp E et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160-74.
2. Favaloro EJ. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Blood Rev 1999; 13: 185-204.
3. Federici AB. Classification of inherited von Willebrand disease and implications in clinical practice. Thromb Res 2009; 124(Suppl. 1): S2-6.
4. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004; 351: 683-94.
5. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998; 67: 395-424.
6. Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003; 1: 1335-42.
7. Weiss HJ, Hoyer LW, Rickles FR, Varma N, Rogers J. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 1973; 52: 2708-16.
8. Kumar S, Pruthi RK, Nichols WL. Acquired von Willebrand disease. Mayo Clin Proc 2002; 77: 181-7.
9. Sadler JE, Budde U, Eikenboom JC et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
10. Bird AR, Sacks R, Smith A. Assay of ristocetin cofactor: experience with a platelet counting technique. Med Lab Sci 1984; 41: 38-45.
11. Zaleski A, Olson JD. A rapid assay for von Willebrand factor. Thromb Res 1988; 51: 462-8.
12. Flood VH, Gill JC, Morateck PA et al. Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD. Blood 2011; 117: e67-74.
13. Lawrie AS, Stufano F, Canciani MT, Mackie IJ, Machin SJ, Peyvandi F. A comparative evaluation of a new automated assay for von Willebrand factor activity. Haemophilia 2013; 19: 338-42.
14. Verfaillie CJ, De Witte E, Devreese KM. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease. Int J Lab Hematol 2013; 10. doi: 10.1111/ijlh.12087.[Epub ahead of print].
15. MacFarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, McPherson J. A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 1975; 34: 306-8.
16. Cattaneo M, Lecchi A, Agati B, Lombardi R, Zighetti ML. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 1999; 96: 213-7.
17. Federici AB, Canciani MT, Forza I et al. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89: 77-85.
18. Lattuada A, Preda L, Sacchi E, Gallo L, Federici AB, Rossi E. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000). Blood Coagul Fibrinolysis 2004; 15: 505-11.
19. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician 1987; 32: 307-17.
20. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-7.
21. O'Donnell J, Laffan MA. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 2001; 11: 343-51.